연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
1205. Development of multiplex PCR method for the analysis of glutathione s-transferase polymorphism.
Kim MS, Kang HJ, Park HJ, Yook YJ, Han BD, Kim CW, Kim NH, Lee JW, Kim H, Park KD, Shin HY, Ahn HS.
Mol Diagn Ther. 2011 Oct 1;15(5):285-92. doi: 10.2165/11592520-000000000-00000.
Link
1204. Establishment and characterization of six human lung cancer cell lines: EGFR, p53 gene mutations and expressions of drug sensitivity genes.
Ku JL, Kim KH, Choi JS, Jeon YK, Kim SH, Shin YK, Kim TY, Bang YJ, Kim WH, Park JG.
Cell Oncol (Dordr). 2011 Feb;34(1):45-54. Epub 2011 Feb 2.
Link
1203. Resistance of colorectal cancer cells to radiation and 5-FU is associated with MELK expression.
Choi S, Ku JL.
Biochem Biophys Res Commun. 2011 Aug 26;412(2):207-13. Epub 2011 Jul 22.
Link
1202. EGFR gene copy number gain is related to high tumor SUV and frequent relapse after adjuvant chemotherapy in resected lung adenocarcinoma.
Koh Y, Jang B, Jeon YK, Kim TM, Lee SH, Kim DW, Chung DH, Kim YT, Kim YW, Heo DS.
Jpn J Clin Oncol. 2011 Apr;41(4):548-54. Epub 2011 Jan 19.
Link
1201. Clinicopathologic characteristics and outcomes of patients with anaplastic lymphoma kinase-positive advanced pulmonary adenocarcinoma: suggestion for an effective screening strategy for these tumors.
Koh Y, Kim DW, Kim TM, Lee SH, Jeon YK, Chung DH, Kim YW, Heo DS, Kim WH, Bang YJ.
J Thorac Oncol. 2011 May;6(5):905-12.
Link
1200. Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy.
Keam B, Im SA, Park S, Nam BH, Han SW, Oh DY, Kim JH, Lee SH, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Bang YJ.
J Cancer Res Clin Oncol. 2011 Sep;137(9):1301-8. Epub 2011 Jun 30.
Link
1199. Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy.
Keam B, Im SA, Koh Y, Han SW, Oh DY, Cho N, Kim JH, Han W, Kang KW, Moon WK, Kim TY, Park IA, Noh DY, Chung JK, Bang YJ.
BMC Cancer. 2011 Oct 20;11:452.
Link
1198. Novel F141L pre-S2 mutation in hepatitis B virus increases the risk of hepatocellular carcinoma in patients with chronic genotype C infections.
Mun HS, Lee SA, Kim H, Hwang ES, Kook YH, Kim BJ.
J Virol. 2011 Jan;85(1):123-32. Epub 2010 Oct 20.
Link
1197. Naturally occurring hepatitis B virus X deletions and insertions among Korean chronic patients.
Lee SA, Mun HS, Kim H, Lee HK, Kim BJ, Hwang ES, Kook YH, Kim BJ.
J Med Virol. 2011 Jan;83(1):65-70.
Link
1196. Gender disparity in distribution of the major hydrophilic region variants of hepatitis B virus genotype C according to hepatitis B e antigen serostatus.
Lee SA, Cho YK, Lee KH, Hwang ES, Kook YH, Kim BJ.
J Med Virol. 2011 Mar;83(3):405-11. doi: 10.1002/jmv.21988.
Link